Transkript signature

Last updated on: 24.11.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

In a biological context, a transcript signature refers to a characteristic pattern of specific gene expression. As a genetic signature, the transcript signature indicates which genes are upregulated or downregulated in a certain situation, e.g. in an inflammatory skin disease, i.e. their activity level.

General informationThis section has been translated automatically.

Transcription itself is a molecular biological process in which the genetic information of a gene is transferred from the DNA to an mRNA copy. The term "signature" in this context refers to the specific process of initiation in which the RNA polymerase binds to the promoter of the gene to start the process of transcription. For example, in bacteria, the so-called sigma factor is the main factor that enables binding to the promoter and thus positions the RNA polymerase, whereas in eukaryotes complex sets of general transcription factors are required.

The transcriptional output of a cell is largely determined by the active enhancer elements contained in its genome. Enhancers were first described as DNA sequences in the 1980s. They increase the expression of a linked gene regardless of its distance and orientation (Moreau P et al. 1981).

ClinicThis section has been translated automatically.

For example, systemic lupus erythematosus (SLE) has a characteristic interferon (IFN) signature. IFN types, both individually and in combination, define different clinical and molecular subtypes in SLE. Thus, high IFN-II/-III levels without IFN-I had little effect on disease activity, IFN-II was associated with IFN-I-independent transcriptional profiles (e.g. OXPHOS and CD8 + GZMH + cells), and IFN-III enhanced IFN-induced gene expression when concomitantly increased with IFN-I (Gómez-Bañuelos E et al. 2024).

Note(s)This section has been translated automatically.

In a non-medical context, a transcript signature is also referred to as the insertion of a digital signature into a document.

LiteratureThis section has been translated automatically.

  1. Lewis MW et Al: (2019) Transcriptional control by enhancers and enhancer RNAs. Transcription 10(4-5):171-186.
  2. Liu F (2017) Enhancer-derived RNA: A Primer. Genomics Proteomics Bioinformatics 15:196-200.
  3. Moreau P et al. (1981) The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res 9:6047-6068.
  4. Ryan RJ et al. (2015) Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Cancer Discov 5:1058-1071.
  5. Sur I et al. (2016) The role of enhancers in cancer. Nat Rev Cancer 16:483-93
  6. Gómez-Bañuelos E et al. (2024) Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE. Cell Rep Med 5:101569.

Last updated on: 24.11.2025